These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G; Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401 [TBL] [Abstract][Full Text] [Related]
51. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada. MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718 [TBL] [Abstract][Full Text] [Related]
52. From Smoke to Smother: Secondary Sarcoma following Stem Cell Transplantation for Thalassemia. Haeuser S; Nissen J; Greil J; Duerken M; Karremann M Klin Padiatr; 2016 Nov; 228(6-07):339-340. PubMed ID: 27442142 [No Abstract] [Full Text] [Related]
53. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271 [TBL] [Abstract][Full Text] [Related]
55. Increased incidence of fractures in recipients of hematopoietic stem-cell transplantation. Pundole XN; Barbo AG; Lin H; Champlin RE; Lu H J Clin Oncol; 2015 Apr; 33(12):1364-70. PubMed ID: 25779562 [TBL] [Abstract][Full Text] [Related]
56. Late Complications and Quality of Life after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation. Clavert A; Peric Z; Brissot E; Malard F; Guillaume T; Delaunay J; Dubruille V; Le Gouill S; Mahe B; Gastinne T; Blin N; Harousseau JL; Moreau P; Milpied N; Mohty M; Chevallier P Biol Blood Marrow Transplant; 2017 Jan; 23(1):140-146. PubMed ID: 27751934 [TBL] [Abstract][Full Text] [Related]
57. Late effects after hematopoietic stem cell transplantation--critical issues. Tichelli A; Rovó A; Socié G Curr Probl Dermatol; 2012; 43():132-49. PubMed ID: 22377926 [TBL] [Abstract][Full Text] [Related]
58. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study. Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277 [TBL] [Abstract][Full Text] [Related]
59. The sources and uses of hematopoietic stem cells keep increasing. Trigg ME Del Med J; 1998 Sep; 70(9):387-92. PubMed ID: 9805406 [TBL] [Abstract][Full Text] [Related]
60. Adverse Late and Long-Term Treatment Effects in Adult Allogeneic Hematopoietic Stem Cell Transplant Survivors. Mosesso K Am J Nurs; 2015 Nov; 115(11):22-34; quiz 35. PubMed ID: 26473441 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]